Cochrane Skin is pleased to announce the publication of a new review, Topical anti‐inflammatory treatments for eczema: network meta‐analysis. 

Cochrane Skin is pleased to announce the publication of a new review, Educational and psychological interventions for managing atopic dermatitis (eczema).  

We're delighted to announce the availability of the replays!

We are delighted to announce the availability of our new podcast titled Which medicines, taken by mouth or injected, work best to treat a skin condition called plaque psoriasis ? discussing the recently updated fourth edition review on systemic treatments for psoriasis, released in July 2023.

Cochrane Skin is pleased to announce the publication of a new review, Treatments for alopecia areata.

 

Discover our new clinical vignette on strategies for using topical corticosteroids in patients with eczema on this link.

Cochrane Skin is pleased to announce the publication of the updated version of the living review Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis. This new version included 179 randomized clinical trials with 62,339 participants with moderate to severe psoriasis.Key messages

Cochrane Skin is pleased to announce the publication of a new review, Interventions for bullous pemphigoid. This updated review included 14 randomized clinical trials with 442 participants diagnosed with bullous pemphigoid.Key messages

The 2022 Cochrane Review Group Impact Factor for the Cochrane Skin Group increased to 9.258.